Skip to content
  • Home
  • HydraSolve T2D
  • Other Applications
  • Our Team
    • Board Directors
    • Management Team
  • News
  • Contact
Menu
  • Home
  • HydraSolve T2D
  • Other Applications
  • Our Team
    • Board Directors
    • Management Team
  • News
  • Contact

Richard D’Amico, MD

Post navigation
← Previous board
Next board →

Recent Posts

  • Medality Medical Commences Clinical Trial for Type 2 Diabetes
  • Medality Medical LLC Named Company Most Likely to Succeed at the 2019 NJ Tech Council Venture Conference
  • Medality Medical™ LLC Appoints Laurence Hirsch, MD, FACP, as Chief Medical Advisor
  • Medality Medical™ LLC Receives FDA Investigational Device Exemption Approval for Reversal of Type 2 Diabetes Clinical Trial
  • Andrew Technologies Announces World’s First Successful Mesenteric Fat Extraction, a Long-Awaited Breakthrough for Potential Reversal of Diabetes

Archives

  • September 2019
  • July 2019
  • March 2019
  • February 2019
  • October 2016
  • September 2016

Categories

  • News

Copyright 2023 Medality Medical, All rights Reserved. | Privacy & Terms

Site design by Leftcoast Studios

Linkedin Twitter Youtube
Medality Medical Financial Conflict of Interest Policy
Medality Medical strives to create a research climate that promotes objectivity in research by establishing standards such that the design, conduct and reporting of Public Health Service (PHS, which includes NIH) funded research is free from bias resulting from financial conflict of interest (FCOI). This policy is applicable to each employee who is planning to or is participating in research activity that is either partially or wholly supported by PHS funds. Each such employee must:
  • disclose his or her significant financial interests (SFI) in non-Medality Medical entities that would appear to be related to the employee’s professional responsibilities on behalf of Medality Medical;
  • comply with an FCOI management plan, if an FCOI is identified; and
  • undergo FCOI training, at least once every four years.
Disclosure of SFI is essential for Medality Medical to determine if an FCOI exists, and in cases of FCOI determine how it will be managed and reported in full compliance with government regulation.